Shelter Pharma Ltd — Important, 28-05-2026: Company Update

Shelter Pharma has confirmed that the utilization of funds raised from its Preferential Issue of Warrants, totaling Rs. 25.31 crore, had no deviation from the approved purpose of meeting working capital requirements. The company received Rs. 9.30 crore as initial subscription for 88.08 lakh warrants and an additional Rs. 16.01 crore upon conversion of 50.52 lakh warrants into equity shares. This update assures shareholders that the capital raised is being used as planned, which is crucial for operational transparency and investor confidence.